" class="no-js "lang="en-US"> John Tsai - Medtech Alert
Tuesday, August 12, 2025
John Tsai

John Tsai

About John Tsai

Honored to lead a dedicated team advancing a robust pipeline covering more than 160 projects in clinical development targeting around 50 diseases. All of this in hopes to change the standard of care for patients around the world. We have a particular passion to apply technologies such as artificial intelligence and data science to the challenge of developing new medicines.

Related Story

Novartis Announces Iptacopan Met Phase II Study Primary Endpoint in Rare Kidney Disease IgA Nephropathy (IgAN)

June 7 2021

Novartis today announced Phase II primary endpoint data showing investigational iptacopan (LNP023) – a first-in-class, […]